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Staphylococcus epidermidis has recently become known as a common cause of 
nosocomial infections, predominantly in patients with indwelling medical devices. 
Although, S. epidermidis infections only rarely develop into life-threatening diseases, 
they are very frequent and difficult to treat due to the ability of this bacterium to adhere 
to the surfaces of indwelling medical devices and form biofilms. A biofilm is a 
three‐dimensional microbial structure consisting of a multicellular community 
composed of cells embedded in a matrix composed, at least partially, of material 
synthesized by the sessile cells in the community. When S. epidermidis cells are in a 
biofilm they are more resistant to antibiotics and to the immune system. The 
importance of biofilms in the pathogenesis of the S. epidermidis infections is becoming 
more understandable, consequently several studies are needed, in order to develop 
effective methods for biofilm control. The use of (bacterio)phages to eradicate biofilms 
has been considered a potentially valuable approach. Phages are virus that infect 
bacteria and are the most abundant organisms on Earth. They are generally very 
efficient antibacterial agents and possess many advantages over antibiotics. Our aim 
is to search for virulent phages with broad host range for S. epidermidis biofilm 
therapy. Using wastewater treatment plants raw effluents we were able to isolate 5 
phages. Their activity against 40 clinical S. epidermidis isolates with different genetic 
profiles was screened and was found to be different ranging from 46% to 95% of 
positive results. Further morphologic and genetic characterization of these isolated 
phages is now being performed. Preliminary results show that, one of the phages 
(phiIBB-Se1), using a MOI of 1 is able to cause a 6 Log CFU/ml reduction of the cell 
titre in <2h for some of the clinical strains at exponential phase and in <4h for 
stationary phase cells. This phage has also the capacity of reducing by up to 2 Log 
CFU/ml 24h biofilm cells. These are promising results, since phage phiIBB-Se1 
presents a broad host range and ability to control S. epidermidis under different 
metabolic states. Ongoing studies are being performed with 4 other phages, with the 
purpose of developing a phage cocktail to be used against S. epidermidis biofilm 
infections. 
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